Genocury Biotech Ltd. is a R&D biotechnology corporation, which commits to the research of cell and gene therapies(CGT) targeting various tumor, we also hope to offer the most promising geneeral treatment therapy options. The R&D team of Genocury are all experienced personnel in the field of CGT. Independently, they has already built an in-vivo CAR-T technology platform, and iPS reprogramming and directional differentiation platform. Right now, Genocury is actively promoting multiple cell products into clinical studies.